» Articles » PMID: 27696523

Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions

Overview
Specialty Psychiatry
Date 2016 Oct 4
PMID 27696523
Citations 187
Authors
Affiliations
Soon will be listed here.
Abstract

Alcohol use is common among people living with human immunodeficiency virus (HIV). In this narrative review, we describe literature regarding alcohol's impact on transmission, care, coinfections, and comorbidities that are common among people living with HIV (PLWH), as well as literature regarding interventions to address alcohol use and its influences among PLWH. This narrative review identifies alcohol use as a risk factor for HIV transmission, as well as a factor impacting the clinical manifestations and management of HIV. Alcohol use appears to have additive and potentially synergistic effects on common HIV-related comorbidities. We find that interventions to modify drinking and improve HIV-related risks and outcomes have had limited success to date, and we recommend research in several areas. Consistent with Office of AIDS Research/National Institutes of Health priorities, we suggest research to better understand how and at what levels alcohol influences comorbid conditions among PLWH, to elucidate the mechanisms by which alcohol use is impacting comorbidities, and to understand whether decreases in alcohol use improve HIV-relevant outcomes. This should include studies regarding whether state-of-the-art medications used to treat common coinfections are safe for PLWH who drink alcohol. We recommend that future research among PLWH include validated self-report measures of alcohol use and/or biological measurements, ideally both. Additionally, subgroup variation in associations should be identified to ensure that the risks of particularly vulnerable populations are understood. This body of research should serve as a foundation for a next generation of intervention studies to address alcohol use from transmission to treatment of HIV. Intervention studies should inform implementation efforts to improve provision of alcohol-related interventions and treatments for PLWH in healthcare settings. By making further progress on understanding how alcohol use affects PLWH in the era of HIV as a chronic condition, this research should inform how we can mitigate transmission, achieve viral suppression, and avoid exacerbating common comorbidities of HIV and alcohol use and make progress toward the 90-90-90 goals for engagement in the HIV treatment cascade.

Citing Articles

Addressing Pain and Heavy Drinking among Patients in HIV-Care: A Pilot Study of an Integrated Telehealth Intervention.

Palfai T, Kratzer M, Taylor J, Otis J, Winter M AIDS Behav. 2025; .

PMID: 39998790 DOI: 10.1007/s10461-025-04660-8.


Identifying barriers and facilitators to psychosocial care for people living with HIV in Ireland: a mixed methods study.

Burke A, Davoren M, Arensman E, Harrington J BMC Public Health. 2025; 25(1):707.

PMID: 39979953 PMC: 11843745. DOI: 10.1186/s12889-025-21906-1.


Something to talk about; crosstalk disruption at the neurovascular unit during HIV infection of the CNS.

Galpayage Dona K, Benmassaoud M, Gipson C, McLaughlin J, Ramirez S, Andrews A NeuroImmune Pharm Ther. 2025; 3(2):97-111.

PMID: 39958876 PMC: 11823645. DOI: 10.1515/nipt-2024-0003.


Economic and relationship-strengthening intervention to reduce alcohol use in couples living with HIV in Malawi: a study protocol for a randomised controlled trial of Mlambe.

Mkandawire J, Ssewamala F, Hahn J, Mulauzi N, Neilands T, Tebbetts S BMJ Open. 2025; 15(2):e097247.

PMID: 39929508 PMC: 11815408. DOI: 10.1136/bmjopen-2024-097247.


Harmonization of alcohol use data and mortality across a multi-national HIV cohort collaboration.

Ingle S, Trickey A, Lankina A, McGinnis K, Justice A, Cavassini M Alcohol Clin Exp Res (Hoboken). 2025; 49(2):407-417.

PMID: 39779221 PMC: 11828971. DOI: 10.1111/acer.15522.


References
1.
Parsons J, Rosof E, Mustanski B . Patient-related factors predicting HIV medication adherence among men and women with alcohol problems. J Health Psychol. 2007; 12(2):357-70. PMC: 1855241. DOI: 10.1177/1359105307074298. View

2.
Marcondes M, Watry D, Zandonatti M, Flynn C, Taffe M, Fox H . Chronic alcohol consumption generates a vulnerable immune environment during early SIV infection in rhesus macaques. Alcohol Clin Exp Res. 2008; 32(9):1583-92. PMC: 2579901. DOI: 10.1111/j.1530-0277.2008.00730.x. View

3.
Peters M, Terrault N . Alcohol use and hepatitis C. Hepatology. 2002; 36(5 Suppl 1):S220-5. PMC: 4123319. DOI: 10.1053/jhep.2002.36811. View

4.
Thaler N, Sayegh P, Kim M, Castellon S, Hinkin C . Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease. Arch Clin Neuropsychol. 2015; 30(2):114-21. PMC: 4402335. DOI: 10.1093/arclin/acu092. View

5.
Brenchley J, Price D, Schacker T, Asher T, Silvestri G, Rao S . Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006; 12(12):1365-71. DOI: 10.1038/nm1511. View